Thiogenesis Therapeutics, Corp. (TTIPF)
About Thiogenesis Therapeutics, Corp.
THIOGENESIS THERAPEUTICS
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Thiogenesis Therapeutics, Corp. (TTIPF) Stock Price
- Trading 84% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Thiogenesis Therapeutics, Corp..
Write a review
Thiogenesis Therapeutics, Corp.: frequently asked questions
Is Thiogenesis Therapeutics, Corp. an American company?
Thiogenesis Therapeutics, Corp. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Thiogenesis Therapeutics, Corp. publicly traded?
Yes — Thiogenesis Therapeutics, Corp. is a publicly traded company. Its stock trades under the ticker symbol TTIPF on the OTC.
